0,1
6.2.2.5 Guidelines for the treatment of intermediate-risk disease*,
"Recommendations
Strength rating",
Radical prostatectomy (RP),
"Offer RP to patients with cN0 disease as part of multi-modal therapy. 
Weak",
Radiotherapeutic treatment,
"Offer IMRT/VMAT plus IGRT to the prostate in combination with long-term ADT and 
2 years of abiraterone to cN0M0 patients with > 2 high-risk factors (cT3-4, Gleason 
> 8 or PSA > 40 ng/mL).",Strong
"Offer IMRT/VMAT plus IGRT to the prostate plus pelvis in combination with  
long-term ADT and 2 years of abiraterone to cN1M0 patients.",Strong
"Offer patients with cN1 disease a local treatment (either RP or IMRT/VMAT plus 
IGRT) plus long-term ADT.",Strong
